Related Experiment Videos

[Intrarenal small tumor of the kidney]

Khirurgiia
|July 17, 2003
PubMed

Insights

Organ-sparing surgery for small intrarenal tumors, including renal cell cancer, shows promising survival rates. Nephrotomy and enucleoresection offer effective treatment options for select kidney tumor cases.

Area of Science:

  • Urology
  • Nephrology
  • Surgical Oncology

Background:

  • Kidney tumors are a significant clinical concern.
  • Small tumors (up to 4 cm) represent a subset requiring specific management strategies.
  • Intrarenal tumor localization influences surgical approach.

Purpose of the Study:

  • To evaluate the outcomes of organ-sparing surgery for small intrarenal tumors.
  • To assess the efficacy of nephrotomy and enucleoresection for intrasinus tumors.
  • To analyze the follow-up results for patients treated with these techniques.

Main Methods:

  • Retrospective analysis of 436 patients treated for kidney tumors from 1992-2002.
  • Focus on 143 patients diagnosed with small kidney tumors (≤4 cm).
  • Detailed review of surgical procedures (radical nephrectomy, nephrotomy, enucleoresection) and patient outcomes.

Main Results:

  • 35 patients had intrarenal tumors, with 18 intrasinus and 17 near the capsule.
  • 31 patients with small intrarenal tumors underwent radical nephrectomy.
  • Four patients had nephrotomy and enucleoresection for intrasinus tumors; 3 with renal cell cancer and 1 with angiomyolipoma are alive after follow-up.

Conclusions:

  • Organ-sparing surgery, including nephrotomy and enucleoresection, is a viable option for selected small intrarenal tumors.
  • These techniques demonstrate favorable outcomes, particularly for renal cell cancer and angiomyolipoma.
  • Careful patient selection is crucial for successful organ-sparing kidney tumor treatment.

Related Concept Videos